Vitamin D3 Regimens to See If They Lower Preeclampsia Risk
Official title: Effect of Different Dosages of Vitamin D3 Supplementation on the Risk of Preeclampsia in Pregnant Women With Vitamin D Deficiency
Run by Sana'a University · NCT07648706 · Data updated 2026-11-12
In pregnant women with vitamin D deficiency, this trial tests whether two different vitamin D3 dosing schedules can reduce the chance of developing preeclampsia.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 40 Years |
| Sex | Women only |
| Enrollment | 268 (estimated) |
| Sponsor | Sana'a University Academic / other |
| Locations | 1 site (Sanaa, Maeen District) |
| Status | Recruiting |
| Started | August 4, 2024 |
| Main results expected | August 2026 |
| Study ends | September 2026 |
| Registry record updated | June 15, 2026 |
| Trial ID | NCT07648706 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Pregnant women between 8 and 18 weeks with singleton pregnancy and 25(OH)D < 25 ng/mL who plan to deliver at Al-Thawra Modern General Hospital.
✕Probably not a fit
Those without vitamin D deficiency or with uncontrolled chronic conditions may not experience benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized controlled trial compares two vitamin D3 dosing regimens in pregnant women with confirmed vitamin D deficiency. Participants with singleton pregnancies between 8 and 18 weeks gestation and low 25(OH)D levels are assigned to either 50,000 IU of vitamin D3 every two weeks or 5,000 IU weekly, in addition to standard prenatal care. The primary outcome is the incidence of preeclampsia, with maternal vitamin D status and pregnancy outcomes as secondary measures. The study is conducted at Al-Thawra Modern General Hospital in Sana'a, Yemen, led by Sana'a University, with careful exclusion of conditions that could confound results. The goal is to determine if dosing strategy influences preeclampsia risk in deficient pregnant women.
Why it matters
Potential benefit: If successful, the regimen(s) could offer a practical approach to lowering preeclampsia risk in vitamin D deficient pregnancies.
How similar studies have gone: Previous research has linked vitamin D deficiency to higher preeclampsia risk, but optimal dosing schedules remain uncertain and this trial tests two regimens directly.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Singleton pregnancy * Pregnant women between 8 and 18 weeks of gestation * Serum 25-hydroxyvitamin D \[25(OH)D\] level \< 25 ng/mL * Willing and able to provide written informed consent * Planning to receive ongoing antenatal care and deliver at Al-Thawra Modern General Hospital. Exclusion Criteria: * Uncontrolled chronic hypertension * Current use of vitamin D supplementation before enrollment * Severe chronic kidney disease * Pre-existing diabetes mellitus * Autoimmune or immunological disorders * Known fetal congenital anomalies * Primary hyperparathyroidism * Thyroid disease * Use of medications that affect vitamin D or calcium metabolism * Inability or unwillingness to comply with the study protocol or follow-up schedule
Where it's running
-
Faculty of Medicine and Health Sciences, Sana'a University
Sanaa, Maeen District, Yemen Recruiting
Study contacts
- Principal investigator: Amany Omer Taib, MBBS — Faculty of Medicine and Health Sciences, Sana'a University
- Study coordinator: Amany Omer Taib, MBBS
- Email: a.taib@su.edu.ye
- Phone: +967775851225
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Predicting Adverse Pregnancy Outcomes in Uganda through Partnerships and Innovation
This study tests whether everyday health data, ultrasound, and blood samples from first-time pregnant women in Uganda can help predict problems like preeclampsia, fetal growth restriction, and preterm birth.
-
Internal jugular vein collapsibility to gauge volume status in preeclampsia vs. normal pregnancy
This study tests whether ultrasound of the internal jugular vein can show differences in fluid status between preeclamptic pregnant people and those with normal blood pressure during planned cesarean delivery.
-
Higher vs lower daily aspirin in high-risk pregnant people
This study tests whether taking 150 mg of aspirin daily is more effective than 75 mg daily in preventing preeclampsia among pregnant people at high risk.
-
Community health worker support to lower blood pressure after pregnancy with high blood pressure
Postpartum patients with high blood pressure after pregnancy will try a program where a trained community health worker helps them monitor blood pressure and manage care for 6 months to see if it lowers blood pressure compared with usual care.
-
Role of Progesterone Membrane Receptors in Preeclampsia
This study looks at whether the levels of progesterone membrane receptors in the placenta differ between women with preeclampsia and healthy pregnant women to understand the condition better.
-
Endothelial Biomarkers in Pregnancy: Endothelial Extracellular Vesicles and Hypertensive Disorders
This study tests whether endothelial extracellular vesicles in the blood differ between normotensive pregnant women and those with hypertensive disorders of pregnancy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.